Appointment booking for Dr. Rosalia Lomeo, MD is currently not available.Dr. Rosalia Lomeo, MD has not yet fully activated their profile on DiabetesIQ.
Dr. Rosalia Lomeo, MD (she/her) is a Rheumatologist in Fredericksburg, VA with over 17 years of experience. What is your opinion of Dr. Rosalia Lomeo, MD? Rate this provider below so other people can make informed decision.
Gender
Female
Experience
Over 17 Years of Experience
Languages Spoken
English
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Rosalia Lomeo, MD has received over $20,521 which includes payments from the following companies:
$2,131.07 from Amgen Inc.
$1,973.47 from Pfizer Inc.
$1,873.22 from AbbVie, Inc.
$1,255.64 from Genentech USA, Inc.
$1,250.66 from Janssen Biotech, Inc.
$1,037.98 from Novartis Pharmaceuticals Corporation
$1,037.08 from UCB, Inc.
$1,014.26 from LILLY USA, LLC
$981.15 from GlaxoSmithKline, LLC.
$820.05 from Horizon Pharma plc
$800.95 from Mallinckrodt LLC
$589.45 from Egalet US Inc
$588.47 from E.R. Squibb & Sons, L.L.C.
$479.02 from Teva Pharmaceuticals USA, Inc.
$440.47 from Celgene Corporation
$423.34 from Purdue Pharma L.P.
$339.39 from Antares Pharma, Inc.
$307.39 from Vertical Pharmaceuticals, LLC
$272.17 from MEDAC PHARMA, INC.
$261.73 from Regeneron Healthcare Solutions, Inc.
Payments received by Dr. Rosalia Lomeo, MD were from the following categories:
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!